Published in Br J Dermatol on August 01, 1996
Cutaneous sarcoidosis. Postgrad Med J (1998) 0.99
Skin as a marker of internal disease: a case of sarcoidosis. Indian J Dermatol (2011) 0.75
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell (1998) 2.24
Neonatal neutropenia in low birthweight premature infants. Am J Perinatol (1995) 1.74
C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
Fastest reduction of posttraumatic edema: continuous cryotherapy or intermittent impulse compression? Foot Ankle Int (1997) 1.52
Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. Br J Dermatol (1998) 1.47
Human mast cells produce IL-8. J Immunol (1993) 1.44
Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol (2001) 1.44
Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol (1999) 1.40
Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol (1994) 1.39
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
[Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr (1998) 1.38
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am (2006) 1.38
Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol (2000) 1.33
The beta-tubulin gene family of Arabidopsis thaliana: preferential accumulation of the beta 1 transcript in roots. Gene (1988) 1.31
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Primary carcinoma of ectopic axillary breast tissue. J Eur Acad Dermatol Venereol (2006) 1.26
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol (1997) 1.16
Coexisting lichen planus and subacute cutaneous lupus erythematosus. Clin Exp Dermatol (1995) 1.13
Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders? Exp Dermatol (1999) 1.13
Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood (1998) 1.12
Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol (1996) 1.10
Stabilization of proximal tibial fractures with the LIS-System: early clinical experience in Berlin. Injury (2003) 1.10
Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer (1996) 1.09
Miliaria crystallina in an intensive care setting. Clin Exp Dermatol (2004) 1.08
Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol (1998) 1.06
The beta-tubulin gene family in Zea mays: two differentially expressed beta-tubulin genes. Plant Mol Biol (1990) 1.04
Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol (1995) 1.04
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Treatment of femoral shaft fractures in children by external fixation. Injury (1991) 1.02
Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes. J Invest Dermatol (1997) 1.02
Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res (1996) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol (1999) 1.01
PO2-profiles in hippocampal slices of the guinea pig. Exp Brain Res (1982) 0.99
Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol (1997) 0.99
Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse (1996) 0.99
Autosomal dominant lamellar ichthyosis: a new skin disorder. Clin Genet (1984) 0.98
Ichthyosis bullosa of Siemens: a unique type of epidermolytic hyperkeratosis. J Am Acad Dermatol (1986) 0.98
Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis. Allergy (2005) 0.97
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol (2000) 0.97
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer (2003) 0.97
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Molecular regulation of human IgE synthesis. J Mol Med (Berl) (1997) 0.95
[Vertebroplasty and kyphoplasty in osteoporotic fractures of vertebral bodies -- a prospective 1-year follow-up analysis]. Rofo (2005) 0.95
Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol (2003) 0.94
Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol (2005) 0.94
Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol (2001) 0.94
Pinless external fixation. Indications and preliminary results in tibial shaft fractures. Clin Orthop Relat Res (1998) 0.94
Mastocytosis: recent advances in defining the disease. Br J Dermatol (2001) 0.94
Ultrastructural detection of Haemophilus ducreyi in biopsies of chancroid. Arch Dermatol Res (1978) 0.94
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology (1996) 0.93
Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res (1999) 0.93
[Granuloma annulare disseminatum as a rare side effect of allopurinol]. Hautarzt (1996) 0.92
Multiple skin tumors of indeterminate cells in an adult. J Am Acad Dermatol (1986) 0.92
Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol (1996) 0.92
Novel unconventional therapeutic approaches to atopic eczema. Dermatology (2000) 0.91
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol (1999) 0.91
Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases. Arch Dermatol Res (1992) 0.91
Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol (1996) 0.91
Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol (2004) 0.91
Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia (1994) 0.91
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer (2005) 0.91
Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol (2001) 0.90
Microscopic morphology of different types of urticaria. Arch Dermatol (1998) 0.90
Erythema elevatum diutinum--evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol (2000) 0.90
Identification of the bacteriophage T4 unf ( = alc) gene product, a protein involved in the shutoff of host transcription. Genetics (1984) 0.90
Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood (1998) 0.90
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study. Br J Cancer (1998) 0.90
[Distal radius fracture. Fracture stabilization with biodegradable osteosynthesis pins (Biofix). Experimental studies and initial clinical experiences]. Unfallchirurg (1989) 0.90
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Clinical experience with two types of pelvic C-clamps for unstable pelvic ring injuries. Injury (1996) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc (2001) 0.89
Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology (1996) 0.89
Leukoplakia of the prepuce with epidermolytic hyperkeratosis: a case report. Acta Derm Venereol (1983) 0.89
Comparative cytokine gene expression: regulation and release by human mast cells. Immunology (1998) 0.89
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol (2001) 0.88
The scleroatrophic syndrome of Huriez: a cancer-prone genodermatosis. Br J Dermatol (1996) 0.88
Detection of human papillomaviruses in paraffin-embedded condylomata acuminata--comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J Invest Dermatol (1991) 0.88
Hair growth control by immunosuppression. Arch Dermatol Res (1996) 0.87
Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. J Histochem Cytochem (1997) 0.87
Laser-induced weal and flare reactions: clinical aspects and pharmacological modulation. Br J Dermatol (2002) 0.87
Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. Scand J Immunol (1997) 0.87
Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol (2002) 0.87
The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci (2005) 0.87
Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol (1999) 0.86
Homologous growth hormone accelerates bone healing--a biomechanical and histological study. Bone (2003) 0.86
Hair cycle-dependent changes in the gene expression and protein content of transforming factor beta 1 and beta 3 in murine skin. Arch Dermatol Res (1997) 0.86